Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

BACKGROUND: Rifapentine-based regimens have potent antimycobacterial activity that may allow for a shorter course in patients with drug-susceptible pulmonary tuberculosis. METHODS: In an open-label, phase 3, randomized, controlled trial involving persons with newly diagnosed pulmonary tuberculosis f...

全面介紹

Na minha lista:
書目詳細資料
發表在:N Engl J Med
Main Authors: Dorman, Susan E., Nahid, Payam, Kurbatova, Ekaterina V., Phillips, Patrick P.J., Bryant, Kia, Dooley, Kelly E., Engle, Melissa, Goldberg, Stefan V., Phan, Ha T.T., Hakim, James, Johnson, John L., Lourens, Madeleine, Martinson, Neil A., Muzanyi, Grace, Narunsky, Kim, Nerette, Sandy, Nguyen, Nhung V., Pham, Thuong H., Pierre, Samuel, Purfield, Anne E., Samaneka, Wadzanai, Savic, Radojka M., Sanne, Ian, Scott, Nigel A., Shenje, Justin, Sizemore, Erin, Vernon, Andrew, Waja, Ziyaad, Weiner, Marc, Swindells, Susan, Chaisson, Richard E.
格式: Artigo
語言:Inglês
出版: 2021
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8282329/
https://ncbi.nlm.nih.gov/pubmed/33951360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2033400
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍